Kronos Bio, Inc. Quarterly Nonoperating Income (Expense) in USD from Q3 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Kronos Bio, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q3 2019 to Q2 2024.
  • Kronos Bio, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $1.82M, a 24.9% decline year-over-year.
  • Kronos Bio, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $8.33M, a 5.98% increase year-over-year.
  • Kronos Bio, Inc. annual Nonoperating Income (Expense) for 2023 was $9.16M, a 134% increase from 2022.
  • Kronos Bio, Inc. annual Nonoperating Income (Expense) for 2022 was $3.91M, a 1122% increase from 2021.
  • Kronos Bio, Inc. annual Nonoperating Income (Expense) for 2021 was $320K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $8.33M $1.82M -$604K -24.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $8.94M $2.04M -$219K -9.71% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $9.16M $2.02M +$124K +6.53% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $9.03M $2.45M +$1.17M +91.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $7.86M $2.43M +$1.8M +287% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $6.06M $2.26M +$2.15M +2111% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $3.91M $1.9M +$1.83M +2539% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 $2.08M $1.28M +$1.21M +1731% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $871K $627K +$541K +629% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $330K $102K +$10K +10.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $320K $72K +$12.1M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 -$11.8M $70K +$19M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$30.8M $86K -$133K -60.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$30.7M $92K -$262K -74% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$30.4M -$12.1M Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 -$18.9M -$19.2M -6198% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $219K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $354K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 $310K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.